Vitamin D and the risk of dementia and Alzheimer disease
- PMID: 25098535
- PMCID: PMC4153851
- DOI: 10.1212/WNL.0000000000000755
Vitamin D and the risk of dementia and Alzheimer disease
Abstract
Objective: To determine whether low vitamin D concentrations are associated with an increased risk of incident all-cause dementia and Alzheimer disease.
Methods: One thousand six hundred fifty-eight elderly ambulatory adults free from dementia, cardiovascular disease, and stroke who participated in the US population-based Cardiovascular Health Study between 1992-1993 and 1999 were included. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were determined by liquid chromatography-tandem mass spectrometry from blood samples collected in 1992-1993. Incident all-cause dementia and Alzheimer disease status were assessed during follow-up using National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria.
Results: During a mean follow-up of 5.6 years, 171 participants developed all-cause dementia, including 102 cases of Alzheimer disease. Using Cox proportional hazards models, the multivariate adjusted hazard ratios (95% confidence interval [CI]) for incident all-cause dementia in participants who were severely 25(OH)D deficient (<25 nmol/L) and deficient (≥25 to <50 nmol/L) were 2.25 (95% CI: 1.23-4.13) and 1.53 (95% CI: 1.06-2.21) compared to participants with sufficient concentrations (≥50 nmol/L). The multivariate adjusted hazard ratios for incident Alzheimer disease in participants who were severely 25(OH)D deficient and deficient compared to participants with sufficient concentrations were 2.22 (95% CI: 1.02-4.83) and 1.69 (95% CI: 1.06-2.69). In multivariate adjusted penalized smoothing spline plots, the risk of all-cause dementia and Alzheimer disease markedly increased below a threshold of 50 nmol/L.
Conclusion: Our results confirm that vitamin D deficiency is associated with a substantially increased risk of all-cause dementia and Alzheimer disease. This adds to the ongoing debate about the role of vitamin D in nonskeletal conditions.
© 2014 American Academy of Neurology.
Figures
Comment in
-
Dementia: Does vitamin D modulate cognition?Nat Rev Neurol. 2014 Nov;10(11):613-4. doi: 10.1038/nrneurol.2014.193. Epub 2014 Oct 21. Nat Rev Neurol. 2014. PMID: 25330725 No abstract available.
Similar articles
-
Vitamin D is not associated with incident dementia or cognitive impairment: an 18-y follow-up study in community-living old men.Am J Clin Nutr. 2017 Apr;105(4):936-943. doi: 10.3945/ajcn.116.141531. Epub 2017 Feb 15. Am J Clin Nutr. 2017. PMID: 28202477
-
Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia.Alzheimers Dement. 2014 May;10(3):296-302. doi: 10.1016/j.jalz.2013.05.1765. Epub 2013 Jul 18. Alzheimers Dement. 2014. PMID: 23871764
-
Association of serum 25-hydroxyvitamin D concentrations with risk of dementia among individuals with type 2 diabetes: A cohort study in the UK Biobank.PLoS Med. 2022 Jan 13;19(1):e1003906. doi: 10.1371/journal.pmed.1003906. eCollection 2022 Jan. PLoS Med. 2022. PMID: 35025861 Free PMC article.
-
Vitamin D status and risk of dementia and Alzheimer's disease: A meta-analysis of dose-response †.Nutr Neurosci. 2019 Nov;22(11):750-759. doi: 10.1080/1028415X.2018.1436639. Epub 2018 Feb 15. Nutr Neurosci. 2019. PMID: 29447107 Review.
-
Vitamin D and cognitive function.Scand J Clin Lab Invest Suppl. 2012;243:79-82. doi: 10.3109/00365513.2012.681969. Scand J Clin Lab Invest Suppl. 2012. PMID: 22536767 Review.
Cited by
-
Genetic evidence supporting the causal role of 25-hydroxyvitamin D levels in the prognosis of ER- breast cancer: A Mendelian randomization study.Medicine (Baltimore). 2024 Oct 25;103(43):e40262. doi: 10.1097/MD.0000000000040262. Medicine (Baltimore). 2024. PMID: 39470482 Free PMC article.
-
The Moderating Effect of Serum Vitamin D on the Relationship between Beta-amyloid Deposition and Neurodegeneration.Clin Psychopharmacol Neurosci. 2024 Nov 30;22(4):646-654. doi: 10.9758/cpn.24.1189. Epub 2024 Jul 25. Clin Psychopharmacol Neurosci. 2024. PMID: 39420611 Free PMC article.
-
Follow-Up Period Affects the Association between Serum 25-Hydroxyvitamin D Concentration and Incidence of Dementia, Alzheimer's Disease, and Cognitive Impairment.Nutrients. 2024 Sep 23;16(18):3211. doi: 10.3390/nu16183211. Nutrients. 2024. PMID: 39339811 Free PMC article.
-
Osteoporosis as a Potential Modifiable Risk Factor for Dementia in Thailand: A Cross-Sectional Analysis.Cureus. 2024 Jun 30;16(6):e63511. doi: 10.7759/cureus.63511. eCollection 2024 Jun. Cureus. 2024. PMID: 39081449 Free PMC article.
-
Cholecalciferol Supplementation Impacts Behavior and Hippocampal Neuroglial Reorganization in Vitamin D-Deficient Rats.Nutrients. 2024 Jul 19;16(14):2326. doi: 10.3390/nu16142326. Nutrients. 2024. PMID: 39064769 Free PMC article.
References
-
- Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 2013;33:659–674 - PubMed
-
- Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J Alzheimers Dis 2013;37:147–171 - PubMed
-
- Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–281 - PubMed
-
- Thies W, Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimers Dement 2013;9:208–245 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical